Back to PRLD

MARSHALL WACE, LLP → PRLD

MARSHALL WACE, LLP PRLD Position History

Prelude Therapeutics Incorporated • Healthcare

Quarters held
14
Latest value
$539K
Q3 2026
Peak value
$933K
First seen
Q3 2024

Dollar value over time

Show data table
PeriodPosition value
Q3 2024$224K
Q3 2024$520K
Q4 2024$135K
Q4 2024$363K
Q2 2025$10K
Q2 2025$24K
Q4 2025$5K
Q4 2025$789K
Q1 2026$641K
Q1 2026$586K
Q2 2026$84K
Q2 2026$933K
Q3 2026$19K
Q3 2026$539K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$539K137.8K——
Q3 2026$19K5.0K——
Q2 2026$933K175.0K——
Q2 2026$84K15.7K——
Q1 2026$586K171.5K——
Q1 2026$641K187.4K——
Q4 2025$789K272.0K——
Q4 2025$5K1.9K——
Q2 2025$24K30.0K——
Q2 2025$10K11.7K——
Q4 2024$363K285.8K——
Q4 2024$135K106.4K——
Q3 2024$520K251.1K——
Q3 2024$224K108.0K——

Other funds holding PRLD

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B